Latest News & Updates
Breaking News
11 hours ago
Simantini Singh Deo
Other trending news you may like to read
Cytosurge Appoints Luba Greenwood To Board Of Directors To Strengthen AI-Driven Drug Discovery Growth
Cytosurge appoints biotech executive Luba Greenwood to its Board to support AI-driven drug discovery growth.
Simantini Singh Deo
RxSight Appoints Aziz Mottiwala As President And CEO In Planned Leadership Transition
RxSight appoints Aziz Mottiwala as President and CEO, succeeding Ron Kurtz in planned leadership transition.
Simantini Singh Deo
Angelini Pharma Completes Catalyst Pharmaceuticals Acquisition To Expand Global Brain Health Business
Angelini Pharma completes Catalyst Pharmaceuticals acquisition to expand its global brain health business.
Simantini Singh Deo
Diagonal Therapeutics Doses First Patient In Phase 1/2 Trial Of DIAG723 For Rare Vascular Disorder HHT
Diagonal Therapeutics doses first patient in Phase 1/2 trial of DIAG723 for hereditary hemorrhagic telangiectasia.
Simantini Singh Deo
